Rice Hall James & Associates, LLC Y M Abs Therapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 108,684 shares of YMAB stock, worth $1.21 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

108,684

Previous 89,735 21.12%

Holding current value

$1.21 Million

Previous $1.08 Million 31.76%

% of portfolio

0.08%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$9.95 - $15.39 $188,542 - $291,625	18,949 Added 21.12%	108,684 $1.43 Million
Q2 2024 Aug 07, 2024	BUY	$11.6 - $17.25 $41,632 - $61,910	3,589 Added 4.17%	89,735 $1.08 Million
Q1 2024 Apr 23, 2024	BUY	$6.57 - $18.69 $4,158 - $11,830	633 Added 0.74%	86,146 $1.4 Million
Q4 2023 Feb 08, 2024	SELL	$4.88 - $7.42 $27,991 - $42,561	-5,736 Reduced 6.29%	85,513 $583,000
Q3 2023 Nov 02, 2023	SELL	$4.86 - $7.23 $8,616 - $12,818	-1,773 Reduced 1.91%	91,249 $497,000
Q2 2023 Jul 24, 2023	BUY	$5.68 - $10.34 $20,118 - $36,624	3,542 Added 3.96%	93,022 $631,000
Q1 2023 May 11, 2023	BUY	$2.83 - $5.11 $6,763 - $12,212	2,390 Added 2.74%	89,480 $448,000
Q4 2022 Jan 27, 2023	SELL	$3.0 - $15.17 $10,725 - $54,232	-3,575 Reduced 3.94%	87,090 $0
Q3 2022 Nov 01, 2022	SELL	$13.96 - $19.67 $17,212 - $24,253	-1,233 Reduced 1.34%	90,665 $1.31 Million
Q2 2022 Aug 08, 2022	BUY	$8.22 - $15.13 $12,519 - $23,042	1,523 Added 1.69%	91,898 $1.39 Million
Q1 2022 May 05, 2022	BUY	$6.55 - $17.42 $39,169 - $104,171	5,980 Added 7.09%	90,375 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $231,036 - $436,601	-14,896 Reduced 15.0%	84,395 $1.37 Million
Q3 2021 Nov 09, 2021	BUY	$27.47 - $37.31 $69,141 - $93,909	2,517 Added 2.6%	99,291 $2.83 Million
Q2 2021 Jul 29, 2021	SELL	$25.45 - $37.64 $108,264 - $160,120	-4,254 Reduced 4.21%	96,774 $3.27 Million
Q1 2021 May 14, 2021	BUY	$29.16 - $51.96 $991 - $1,766	34 Added 0.03%	101,028 $3.06 Million
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $243,326 - $348,729	6,427 Added 6.8%	100,994 $5 Million
Q3 2020 Nov 16, 2020	BUY	$35.13 - $43.62 $1.06 Million - $1.32 Million	30,241 Added 47.01%	94,567 $3.63 Million
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $16,514 - $34,571	698 Added 1.1%	64,326 $2.78 Million
Q1 2020 May 15, 2020	BUY	$14.39 - $35.8 $346,252 - $861,419	24,062 Added 60.81%	63,628 $1.66 Million
Q4 2019 Jan 29, 2020	BUY	$23.81 - $33.78 $942,066 - $1.34 Million	39,566 New	39,566 $1.24 Million

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Y M Abs Therapeutics, Inc. Transaction History